Literature DB >> 19585947

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.

Chengxuan Qiu1, Miia Kivipelto, Eva von Strauss.   

Abstract

More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society. The etiological factors, other than older age and genetic susceptibility, remain to be determined. Nevertheless, increasing evidence strongly points to the potential risk roles of vascular risk factors and disorders (eg, cigarette smoking, midlife high blood pressure and obesity, diabetes, and cerebrovascular lesions) and the possible beneficial roles of psychosocial factors (eg, high education, active social engagement, physical exercise, and mentally stimulating activity) in the pathogenetic process and clinical manifestation of the dementing disorders. The long-term multidomain interventions toward the optimal control of multiple vascular risk factors and the maintenance of socially integrated lifestyles and mentally stimulating activities are expected to reduce the risk or postpone the clinical onset of dementia, including Alzheimer's disease.

Entities:  

Mesh:

Year:  2009        PMID: 19585947      PMCID: PMC3181909     

Source DB:  PubMed          Journal:  Dialogues Clin Neurosci        ISSN: 1294-8322            Impact factor:   5.986


  202 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

Review 2.  Looking backward to move forward: early detection of neurodegenerative disorders.

Authors:  Steven T DeKosky; Kenneth Marek
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 3.  Clinical trials in mild cognitive impairment: lessons for the future.

Authors:  V Jelic; M Kivipelto; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

4.  Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.

Authors:  Kaarin J Anstey; Chwee von Sanden; Agus Salim; Richard O'Kearney
Journal:  Am J Epidemiol       Date:  2007-06-14       Impact factor: 4.897

5.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

6.  Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure.

Authors:  E Sobel; M Dunn; Z Davanipour; Z Qian; H C Chui
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

7.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

9.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01

Review 10.  An active and socially integrated lifestyle in late life might protect against dementia.

Authors:  Laura Fratiglioni; Stephanie Paillard-Borg; Bengt Winblad
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

View more
  259 in total

Review 1.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

Review 2.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

3.  Correlating heart rate and perceived exertion during aerobic exercise in Alzheimer's disease.

Authors:  Fang Yu; Kristin Bil
Journal:  Nurs Health Sci       Date:  2010-09-01       Impact factor: 1.857

Review 4.  The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

Authors:  Gholamreza Azizi; Shadi S Navabi; Ahmed Al-Shukaili; Mir H Seyedzadeh; Reza Yazdani; Abbas Mirshafiey
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

Review 5.  Guiding research and practice: a conceptual model for aerobic exercise training in Alzheimer's disease.

Authors: 
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-03-23       Impact factor: 2.035

6.  Accuracy of reported family history and effectiveness of medical record requests in genetic counseling for Alzheimer disease.

Authors:  Emily L R Alexander; Rachel K Butler; Colleen Guimond; Blair Butler; A Dessa Sadovnick
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

7.  Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?

Authors:  Polyxeni Stamati; Vasileios Siokas; Athina-Maria Aloizou; Emmanouil Karampinis; Stylianos Arseniou; Valerii N Rakitskii; Aristidis Tsatsakis; Demetrios A Spandidos; Illana Gozes; Panayiotis D Mitsias; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

8.  Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Tyler A Zink; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12-31       Impact factor: 2.035

9.  Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction.

Authors:  Kaarin J Anstey; Ranmalee Eramudugolla; Diane E Hosking; Nicola T Lautenschlager; Roger A Dixon
Journal:  J Prev Alzheimers Dis       Date:  2015

10.  Negative Conditioning of Mitochondrial Dysfunction in Age-related Neurodegenerative Diseases.

Authors:  Sharmelee Selvaraji; Luting Poh; Venkateswaran Natarajan; Karthik Mallilankaraman; Thiruma V Arumugam
Journal:  Cond Med       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.